Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
NIH-funded research links alterations to inflammatory protein, underscores vaccine importance.
Prior research has shown that helminth infection induces both innate and adaptive immune responses.
Understanding how this variant helped people fend off the virus could lead to better ways to protect against COVID.
Breast cancer and lymphoma patients who exercised for just 10 minutes had increased numbers of killer T-cells and natural killer cells.
Study results help explain why some cancers have different prognosis in men and women, and also suggest novel treatment strategies.
People with greater immune resilience may be at lower risk for severe COVID-19, AIDS and recurrent skin cancer, NIAID grantees find.
The findings provide a basis for future studies of the immune system’s role in longevity.
A group of proteins help activate cancer-fighting T cells and also trigger their exhaustion, find Dana Farber and NYU scientists.
NIH-funded study suggests need to boost CD8+ T cell response after infection.
Balyn Zaro, PhD, studies genetic differences in the innate immune system and how they can impact the effectiveness of the meds we take.
The condition may be caused by hidden viral reservoirs that remain in the body after initial infection.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.
A mathematical technique called matrix completion could speed up the development of vaccines for flu and COVID-19 variants.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.